ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 863

Functionally Distinct Pathogenic Subsets of Fibroblasts Exist within the Inflamed Synovial Membrane and Mediate Specific Aspects of Inflammatory Disease Pathology

Adam Paul Croft1, Joana Campos2, Loriane Savary2, Emma Bishop2, Jason Turner1, Guillaume Desanti2, Francesca Barone3, Andrew Filer3 and Chris Buckley2, 1Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 2University of Birmingham, Birmingham, United Kingdom, 3Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Animal models, Fibroblasts, rheumatoid arthritis (RA) and treatment

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Fibroblasts are key effector cells in the persistence of synovial inflammation and joint damage. It is not yet known whether specific subsets of synovial fibroblasts exist, and if so, if they are responsible for the distinct fibroblast mediated features observed in inflammatory arthritis such as invasion of cartilage, bone damage, and persistence of inflammation. Using selective cell deletion strategies and adoptive cellular transfer we demonstrate the presence of functionally distinct subsets of synovial fibroblasts that mediate specific aspects of joint pathology.

Methods: Flow cytometry of digested synovial tissue was performed to determine the expression of fibroblast subsets using a cassette of distinct cell surface makers. Bulk transcriptomics was performed using ultra-low input RNAseq. We utilized a transgenic mouse in which FAP expressing cells were conditionally ablated (FAP-DTR) by administration of diphtheria toxin. Poly-arthritis was performed using either the KRN serum transfer model. Mice were scored for clinical signs of arthritis and MicroCT was performed to evaluate inflammatory bone changes.

Results:

We identified distinct populations of fibroblasts defined by their expression of a cassette of cell surface markers including: podoplanin (PDPN), fibroblast activation protein (FAP), VCAM-1, Cadherin-11 and Thy1.2. Bulk transcriptomic analysis of these targeted subpopulations of cells revealed distinct transcriptional signatures which associated with whether the fibroblast subsets were located in the lining or sub-lining layers of the synovium. Synovial inflammation was associated with activation and selective expansion of these cell subsets with distinct compartments of the synovial membrane. Within the intimal layer of the synovium FAP+ PDPN+ Thy 1- fibroblasts highly express MMPs, proteases and were found within pannus tissue invading articular cartilage and bone. In contrast, PDPN+ FAP+ Thy1+, cells rapidly expand within the sub-intimal layer and express pro-inflammatory cytokines, chemokine and survival factors associated with the recruitment and retention of leucocytes.

Utilising their shared expression of FAP we selectively deleted these cells using the FAP-DTR mouse. The deletion of these cells in vivo lead to attenuation of synovial inflammation, inhibited leucocyte accumulation and protected against inflammatory bone damage and remodelling. Consistent with these findings the adoptive transfer of FAP+, PDPN+ Thy1+ cells into arthric mouse joints lead to a more severe and persistent inflammatory arthritis, ehereas injection of FAP+ PDPN+ Thy1- cells did not.

Conclusion: Synovial inflammation is associated with the expansion, activation and differentiation of fibroblasts into pathogenic distinct functional subsets of cells that regulate those specific aspects of inflammatory joint pathology. Direct targeting of specific pathogenic subsets of synovial fibroblasts may provide a novel, non-immunosuppressive approach to the treatment of inflammatory arthritis.


Disclosure: A. P. Croft, None; J. Campos, None; L. Savary, None; E. Bishop, None; J. Turner, None; G. Desanti, None; F. Barone, None; A. Filer, None; C. Buckley, None.

To cite this abstract in AMA style:

Croft AP, Campos J, Savary L, Bishop E, Turner J, Desanti G, Barone F, Filer A, Buckley C. Functionally Distinct Pathogenic Subsets of Fibroblasts Exist within the Inflamed Synovial Membrane and Mediate Specific Aspects of Inflammatory Disease Pathology [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/functionally-distinct-pathogenic-subsets-of-fibroblasts-exist-within-the-inflamed-synovial-membrane-and-mediate-specific-aspects-of-inflammatory-disease-pathology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functionally-distinct-pathogenic-subsets-of-fibroblasts-exist-within-the-inflamed-synovial-membrane-and-mediate-specific-aspects-of-inflammatory-disease-pathology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology